MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0112818
Chemosyn Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹24.95 Cr
▼ 22% YoY
Net loss · FY 2025
₹19,214
Net margin 0%
EBITDA · FY 2025
₹73.65 Lakh
EBITDA margin 3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹4.51 Cr
Satisfied ₹8.35 Cr
Company age
64 yrs
Est. 1962
Directors on board
3
As per MCA filings
About Chemosyn Limited
Data last updated:
Chemosyn Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 1962 and has been in existence for over 64 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1962PLC012310. Its GSTIN is 27AAACC2044D1ZA (Maharashtra). The company holds 13 GST registrations, of which 11 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Chemosyn Private Limited. It is led by directors including Kanhai Samir Shah (Managing Director) and Aanal Samir Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.95 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹19,214 (net margin 0%) and EBITDA of ₹73.65 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 9% over five years.
The company is associated with 1 brand: Chemosyn. As per MCA filings, the company has open charges of ₹4.51 Cr and satisfied charges of ₹8.35 Cr on record. Court records list 44 cases involving the company, including 23 filed by the company and 21 filed against it; 3 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 4 smaller; the largest is Healkraft Pharma (India) Private Limited with revenue of ₹25.01 Cr. The company has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers.
Chemosyn Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0112818). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemosynltd.com.
Company details
CIN U24239MH1962PLC012310
Registration Number 012310
Incorporation Date 27 March 1962
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0112818
Key People
Kanhai Samir Shah Managing Director Aanal Samir Shah Whole-Time Director Madhav Samir Shah Director Recognitions & Rankings of Chemosyn
Contact details
Chemosyn Limited's registered office is in Mumbai, Maharashtra. Its website is chemosynltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressAkshay Mittal Indl. Premises Cs Ltd Sanjay Bldg. No.5 B Unit No.46 Ground Flr. Andheri, (E), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Chemosyn Limited, buy the company report.
Comprehensive company report
Chemosyn Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Chemosyn operates one associated brand: Chemosyn. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medicines in India. | chemosynltd.com |
Business activity
The main business activity of Chemosyn is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Chemosyn Limited, buy the company report.
Financials of Chemosyn Limited
FY 2025 filings availableChemosyn Limited reported revenue of ₹24.95 Cr (down 22% YoY) for FY 2025.
Revenue · FY 2025
₹24.95 Cr ▼ 22%
Net loss · FY 2025
₹19,214 margin 0%
EBITDA · FY 2025
₹73.65 Lakh margin 3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 11%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 1%
5 years · compounded
▼ 13%
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 22% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹73.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19,214 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Chemosyn Limited, buy the company report.
Board of directors of Chemosyn Limited
Chemosyn has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aanal Samir Shah Also directs: Mahabali Intratrade LLP, Ram Doot Intratrade LLP | Whole-Time Director | 18 Jul 2006 | 20 Years 3 Months | Current |
| Kanhai Samir Shah Also directs: Mahabali Intratrade LLP | Managing Director | 13 Dec 2007 | 18 Years 10 Months | Current |
| Madhav Samir Shah Also directs: Ram Doot Intratrade LLP | Director | 13 Dec 2007 | 18 Years 10 Months | Current |
Peer comparison
Chemosyn Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healkraft Pharma (India) Private Limited | ₹25.01 Cr (FY 2025) | -1.0% | Chennai, Tamil Nadu, India | |||
| Chemosyn Limitedthis company | ₹24.95 Cr (FY 2025) | -₹19,214 | 0% | -22.0% | Mumbai, Maharashtra, India | |
| Thrift Pharmaceuticals Private Limited | ₹24.95 Cr (FY 2024) | 11.0% | Vadodara, Gujarat, India | |||
| Eucare Pharmaceuticals P Ltd | ₹24.93 Cr (FY 2024) | 31.0% | Tamil Nadu, India | |||
| Pyxus Pharmaceuticals Private Limited | ₹24.91 Cr (FY 2025) | -4.0% | Ahmedabad, Gujarat, India | |||
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | 37.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Chemosyn Limited, buy the company report.
Auditor
Chemosyn Limited is audited by SAMIR M. SHAH & ASSOCIATES. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAMIR M. SHAH & ASSOCIATES. | FY 2023 | 122377W |
Shareholding
The shareholding of Chemosyn Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Chemosyn Limited, buy the company report.
Charges & borrowings
Open charges
₹4.51 Cr
Satisfied charges
₹8.35 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Sep 2025 | 101166594 | The Kalupur Commercial Co-Operative Bank Limited | ₹13 Lakh | Open | |
| 17 Sep 2025 | 101166673 | The Kalupur Commercial Co-Operative Bank Limited | ₹72 Lakh | Open | |
| 11 Feb 2010 | 10208727 | The Kalupur Commercial Co-Operative Bank Limited | ₹1.25 Cr | Open | |
| 09 Feb 2010 | 10208728 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.41 Cr | Open | |
| 07 Dec 2016 | 100066257 | Others | ₹70 Lakh | Satisfied |
To see the full charge records of Chemosyn Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Chemosyn Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹83.7 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Funding round | ₹83.7 Lakh | Investors: Ramdoot Intratrade LLP, Mahabali Intratrade LLP , 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Chemosyn Limited has 44 court cases on record: 23 filed by Chemosyn, 21 filed against it. 3 cases are pending and 41 are disposed.
Total cases
44
Filed by the company
23
Filed against the company
21
Pending
3
Disposed
41
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 33 | 16 | 1 |
| Supreme Court | 6 | 2 | 0 |
| District courts | 5 | 3 | 2 |
Cases on record (5 of 44)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Limited | Disposed |
| Bombay High Court | Writ petition | Filed by the company against Union Bank of India | Disposed |
| High Court, GUJARAT | Court case (AO) | Filed by the company against Gujarat Industrial Investment Corporation Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed by the company against Gujarat Industrial Investment Corporation Limited. | Disposed |
To see the full case history of Chemosyn Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Chemosyn Limited has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Laxmi Print Art | |||
| Omkar Traders | |||
| an individual supplier | |||
| Futuristic Packaging Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Chemosyn Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Chemosyn has 13 GST registrations: 11 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
13
Active
11
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACC2044D1ZA | Maharashtra | Active | 01 Jul 2017 |
| 04AAACC2044D1ZI | Chandigarh | Active | 01 Jul 2017 |
| 08AAACC2044D1ZA | Rajasthan | Active | 01 Jul 2017 |
| 09AAACC2044D1Z8 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Chemosyn Limited, buy the company report.
Recent activity
Chemosyn Limited has 8 board changes on record since 2006: 3 appointments and 5 cessations. The latest: Aanal Samir Shah ceased to be Director on 04 Apr 2011.
AGM
Chemosyn Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited of Rs. 2.41 Cr registered on 09 Feb 2010 with Charge ID 10208728 was modified on 22 Sep 2025.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101166594 was registered on 17 Sep 2025.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 0.72 Cr with Charge ID 101166673 was registered on 17 Sep 2025.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited of Rs. 1.25 Cr registered on 11 Feb 2010 with Charge ID 10208727 was modified on 17 Sep 2025.
Filing
Chemosyn Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 19 Apr 2010 via Charge ID 10216602 with The Kalupur Commerical Co-Operative Bank Limited was fully satisfied on 26 May 2022.
Charges
A charge registered on 07 Dec 2016 via Charge ID 100066257 with Others was fully satisfied on 09 Mar 2022.
Charges
A charge registered on 27 Aug 2015 via Charge ID 10587721 with The Kalupur Commercial Co-Operative Bank Limited was fully satisfied on 10 Dec 2020.
Charges
A charge registered on 12 Nov 2012 via Charge ID 10387606 with The Kalupur Commercial Co-Op. Bank Ltd. was fully satisfied on 21 Mar 2018.
Charges
A charge with Others amounted to Rs. 0.70 Cr with Charge ID 100066257 was registered on 07 Dec 2016.
Charges
A charge with The Kalupur Commercial Co-Op. Bank Ltd. of Rs. 0.90 Cr registered on 12 Nov 2012 with Charge ID 10387606 was modified on 21 Sep 2015.
17 earlier events are in the company report.
Frequently asked questions
Chemosyn is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 1962 (64+ years old) and is registered under CIN U24239MH1962PLC012310.
Chemosyn has 3 current directors:
- Kanhai Samir Shah - Managing Director
- Aanal Samir Shah - Whole-Time Director
- Madhav Samir Shah - Director
The latest financial statements of Chemosyn on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Chemosyn is 27AAACC2044D1ZA, registered in Maharashtra. The company has 13 GST registrations in all, of which 11 are active and 2 are cancelled or inactive. Other active GSTINs include 04AAACC2044D1ZI (Chandigarh), 08AAACC2044D1ZA (Rajasthan), 09AAACC2044D1Z8 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Chemosyn is U24239MH1962PLC012310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemosyn has 44 court cases on record: 23 filed by the company and 21 filed against it. 3 are pending. Most are in the high courts.
Chemosyn was incorporated on 27 March 1962, making it 64+ years old. It is registered with the Registrar of Companies, Mumbai.
Chemosyn has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018.
The peers of Chemosyn by revenue are Healkraft Pharma (India) Private Limited, Thrift Pharmaceuticals Private Limited, Eucare Pharmaceuticals P Ltd, Pyxus Pharmaceuticals Private Limited, Artura Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aanal Samir Shah ceased to be Director on 04 Apr 2011. Arvind Balu Thakkar ceased to be Director on 21 Jul 2009. Kanhai Samir Shah ceased to be Additional Director on 27 Sep 2008. Chemosyn has 8 board changes on record in total.
Yes, Chemosyn is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0112818).
Chemosyn has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers. The latest return was filed on 25 Apr 2024.